| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |